11 USD
0
0%
Last update Dec 16, 3:55 PM EST
Post-market
Day range
11
11
Previous close
11
Open
11
Access this stock data via API
Subscribe
Evoke Pharma Inc.
11.00
0
0%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 4.3M 3.8M 3.1M 3.3M
Cost of revenue 102.0K 167.7K 41.6K 118.5K
Gross profit 4.2M 3.6M 3.0M 3.2M
Operating expense
Research & development 5.3K 8.4K 42.8K 0
Selling general and admin 5.3M 5.1M 4.3M 4.4M
Other operating expenses
Operating income -1.1M -1.6M -1.3M -1.2M
Non operating interest income
Income 107.5K 112.5K 118.9K 127.0K
Expense 126.0K 124.7K 123.3K 126.0K
Other income expense
Pretax income -1.2M -1.6M -1.3M -1.2M
Tax provision
Net income -1.2M -1.6M -1.3M -1.2M
Basic EPS -0.5 -0.6 -0.5
Diluted EPS -0.5 -0.6 -0.5
Basic average shares 2.6M 2.6M 2.5M
Diluted average shares 2.6M 2.6M 2.5M
EBITDA -1.0M -1.4M -1.2M -1.1M
Net income from continuing op. -1.2M -1.6M -1.3M -1.2M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Post-market

Exchange is currently open for post-market.
Post market session closes in 2 hours 45 minutes

17:15
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).